Trial NCT06265272
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
- Phase
- Not given
- Sponsor
- Massachusetts General Hospital
- Conditions
- Liver Cirrhosis; Hepatic Cell Carcinoma; Portal Hypertension
- Ages
- 18–99 years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* Liver cirrhosis as diagnosed by imaging and/or clinical data, including pathology
Exclusion Criteria:
* Any contraindication to PET, as in attached screening form
* Any contraindication to MRI, as in attached screening form
* Any contraindication to gadolinium-based contrast agent, including allergy to gadolinium, as in attached screening forms.
* PregnancyPregnancy
* Breast feeding.
* Cumulative radiation exposure for research studies during the prior 12 months, combined with the exposure from this study, > 50 mSv
* Inability to fit in the scanner: weight > 300 lbs or BMI > 33BMI
Restrictions found (2)
- BMIOutrightexclusion
weight > 300 lbs or BMI > 33
Show in the text - PregnancyOutrightexclusionShow in the text
Recruiting in Massachusetts
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School · Charlestown, Suffolk County